Genzyme Corporation Announces Multi-Year Multiple Sclerosis Research Collaboration With Leading Academic Medical Center

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today the formation of a research collaboration with Cleveland Clinic focused on developing new therapeutic approaches to the treatment of MS.

Help employers find you! Check out all the jobs and post your resume.

Back to news